Re-thinking Aids

(NaturalNews) To hear it from the vaccine makers, their vaccines are perfectly safe and have no side effects. A person can receive an unlimited number of vaccines (10, 100 or even 1000) and have absolutely no ill effects, they claim. This is the quack science mythology upon which mass vaccination policies are currently based. But new evidence is emerging that people receiving a seasonal flu shot are made more susceptible to H1N1 swine flu as a result.

CBC News in Canada is now reporting disturbing findings you need to know about: “Four Canadian studies involved about 2,000 people, health officials told CBC News. Researchers found people who had received the seasonal flu vaccine in the past were more likely to get sick with the H1N1 virus.”

The story doesn’t cite the percentage increase in H1N1 virus risk, but it’s apparently enough to give pause to many doctors and infectious disease experts. “We don’t know with this year’s flu shot how it interacts with the pandemic flu shot, so it’s a worry,” said Dr. Michael Gardam in the CBC News article quoted below. He’s the director of infectious diseases prevention and control at the Ontario Agency for Health Protection and Promotion.

The upshot of all this is that Canadian health officials are now scratching their heads, wondering whether the seasonal flu vaccines will actually make the H1N1 pandemic worse!  Read more...

(NaturalNews) There’s a new vaccine for nicotine addiction, and another one for drug addiction. There’s an AIDS vaccines (which doesn’t work) and a vaccine for cervical cancer that’s been approved for use on boys (boys don’t have a cervix). Through the pharmaceutical industry, the big push for vaccines is on!

But why, exactly? Is there suddenly a new rash of epidemic disease requiring vaccine treatments? No, not really. What’s new is the way Big Pharma is latching on to these diseases as new opportunities to sell more drugs.

There’s a huge shift underway from drugs designed for sick people to a whole new class of drugs manufactured for healthy people. The new paradigm is that people need drugs before they get sick, as a sort of “protection” against sickness. Drugs, in essence, are being positioned as nutrients — things the human body needs in order to be healthy. And from the moment you’re born, you’re considered deficient in these drugs. That’s why babies are injected with vaccines within minutes after being born. There’s a strong belief in the medical industry that babies are born deficient in vaccines and that such deficiencies must be “corrected” as soon as possible.

This simple but powerful shift in the marketing strategy of Big pharma has expanded the potential customer based from a subset of the population (people who are sick) to the entire world population. Now, everybody needs a vaccine for something say the drug companies. All that’s necessary for the financial success of these scheme is to convince sick people that they need more drugs (or vaccines), and that’s easily accomplished through disease mongering campaigns (like the current fear push over H1N1 swine flu).  Read more...

The first H1N1 Influenza Vaccine trial testing a candidate 2009 H1N1 influenza vaccine in pregnant lady is launching this week, a report from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health told

“Women are usually at higher risk of developing harsh illness if they become infected with influenza virus while they pregnant, which is why they are strongly encouraged to receive the cyclic influenza vaccine every year.” Report indicates that pregnant women are at more risk for complications from the 2009 H1N1 influenza virus as well, so this trial will provide dangerous information for public health planning.”

The H1N1 Influenza Vaccine trial is being conducted through the NIAID-funded national network of Vaccine and Treatment Evaluation Units (VTEUs).

The American public has revealed once again its remarkable willingness to step up and help during an emergency. The interest in this trial has been strange, and participating medical centers expect to fill all the available slots for volunteers shortly.

Up to 120 women 18 to 39 years of age who are in their second or third trimester (14 to 34 weeks) of pregnancy will be enrolled into this primary trial. Volunteers will receive 15 micrograms or 30 micrograms of a candidate 2009 H1N1 influenza vaccine manufactured. All women will receive a primary injection and a second injection 21 days later. Safety data will be collected and assessed continuously throughout the trial by the study investigators and by an independent safety monitoring team. Study investigators will take blood samples to conclude how the immune system responds to the vaccine at set time points before and following each vaccination. Cord blood also to be collected to calculate maternal antibodies transferred to the infants through the placenta.  Read more...